Rate this Video

Entering Era of Personalized Medicine with Novel Treatments for Cushing's Syndrome

Lynnette K. Nieman, MD, of the National Institutes of Health, discuses three new treatment options for patients with Cushing's syndrome. These medical therapies include the dopamine receptor agonist cabergoline, the somatostatin analog pasireotide and the glucocorticoid receptor antagonist mifepristone.

Dr. Nieman noted that these therapies are often used when patients with Cushing's syndrome have recurred or if surgery is not feasible. She also pointed out that one of the most interesting aspects about these new treatments is that they truly expand clinicians' portfolio of drugs and consequently expand the approaches to treating patients with Cushing's syndrome.

Comments (0)
Add your comment